Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status
Nature Medicine2016Vol. 22(6), pp. 577–578
Citations Over TimeTop 10% of 2016 papers
Marie Schoumacher, Stéphanie Le Corre, Alexandre Houy, Eskeatnaf Mulugeta, Marc‐Henri Stern, Sergio Roman‐Roman, Raphaël Margueron
Related Papers
- → EZH2-Mediated Inactivation of IFN-γ-JAK-STAT1 Signaling Is an Effective Therapeutic Target in MYC-Driven Prostate Cancer(2014)96 cited
- → miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma(2017)42 cited
- → RETRACTED: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2(2021)15 cited
- → BAP1 functions as a tumor promoter in prostate cancer cells through EMT regulation(2020)13 cited
- → Regulation of melanoma malignancy by the RP11-705C15.3/miR-145-5p/NRAS/MAPK signaling axis(2020)7 cited